Natixis’s Xenon Pharmaceuticals XENE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-7,000	Closed	-$322K	–	1225
2023 Q4	$322K	Sell	7,000 -3,000	-30%	-$138K	﹤0.01%	642
2023 Q3	$342K	Buy	10,000 +3,000	+43%	+$102K	﹤0.01%	644
2023 Q2	$270K	Buy	+7,000	New	+$270K	﹤0.01%	696